Glenmark Pharma celebrates as Abbott patent revoked

09-01-2015

Glenmark Pharma celebrates as Abbott patent revoked

Glenmark Pharmaceuticals has been handed victory after the Indian Patent Office (IPO) reversed a ruling that had granted a patent to US company Abbott Biotechnology for its anti-arthritis drug Humira (adalimumab).


Glenmark, Abbott Biotechnology, Indian Patent Office, patent infringement

LSIPR